Utrecht

• DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting
  2023-506115-17-00 5 2024-10-14 Metastatic Colorectal Cancer
• Can we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemi … Recruiting
  2024-514620-17-00 4 2024-10-14 Patients with early-stage rectal cancer (defined as early rectal cance
• TAP-TAU Recruiting
  2023-505430-10-00 10 2024-10-10 Mild cognitive impairment and dementia
• Rituximab-induced remission in CIDP (ReCIX study) Recruiting
  2024-512506-25-00 5 2024-10-07 Chronic inflammatory demyelinating polyneuropathy (CIDP)
• Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting
  2024-514927-40-02 11 2024-10-01 Chronic Subdural Hematoma
• A lower dose olaparib, combined with a drug which inhibits olaparib degradation, to increase tolerability and decrease the price of the trea … Recruiting
  2024-516414-38-00 11 2024-10-01 Cancer
• Efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled clinical trial. (EDIT-CAS) Recruiting
  2023-507782-25-00 10 2024-09-27 Coronary vasomotor dysfunction (spasm)
• PREOPANC-5 Recruiting
  2023-508707-20-00 9 2024-09-19 Borderline resectable pancreatic cancer (BRPC)
• Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NV … Recruiting
  2024-516195-15-00 5 2024-09-10 Advanced NSCLC
• Study evaluating whether giving 177Lu-PSMA-617 to men having a spreading prostate cancer which does not respond well to the current standard … Recruiting
  2022-502408-57-00 5 2024-09-04 Novo metastatic hormone-sensitive prostate cancer (mHSPC) patients hav
• A Phase 1/2, Multicenter Study Evaluating the Safety, Tolerability, and Biodistribution of RCT2100 with Single-Ascending Doses in Healthy Pa … Recruiting
  2024-512169-15-00 7 2024-08-28 Cystic Fibrosis
• Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial) Recruiting
  2023-507692-21-00 3 2024-08-22 Bullous pemphigoid
• HOVON 170 DLBCL: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell ly … Recruiting
  2023-505377-32-00 5 2024-08-15 Diffuse large B-cell lymphoma (DLBCL)
• Darbepoetin for neonatal stroke Recruiting
  2024-513042-12-01 4 2024-08-08 Perinatal Arterial Ischemic Stroke (PAIS)
• Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype Recruiting
  2023-509183-17-00 3 2024-08-01 Colorectal cancer, liver metastases
• OPTIMISE: Optimized Immunosuppression for Corneal Transplantation: a multi-centre randomized controlled clinical trial Recruiting
  2022-500109-41-00 6 2024-07-29 Corneal transplantation, Descemet's Membrane Endothelial Keratoplasty
• Treatment of cancer with Immune Checkpoint Inhibition therapy boosted by High Intensity Focused Ultrasound Histotripsy (the iFOCUS study) Recruiting
  2023-509210-10-00 3 2024-07-26 Metastatic or unresectable solid malignancies. Standard of care treatm
• CLEAR-PATH trial Recruiting
  2024-513363-15-01 11 2024-07-22 (Chronic) Peripheral (occlusive) arterial disease (PAD)
• Study of RMC-6291 and RMC-6236 With Other Anti-Cancer Agents in Patients With RAS G12C-Mutated NSCLC - Subprotocol A Recruiting
  2023-509571-16-00 3 2024-07-17 Lung Cancer
• A study of RMC-6236 in combination with pembrolizumab in participants with nonsmall cell lung cancer with certain mutations -Subprotocol B Recruiting
  2023-509572-42-00 3 2024-07-17 Lung Cancer
• Sentinel lymph node biopsy in patients with parotid gland carcinoma using a combination of 99mTc-nanocolloid and 68Ga-tilmanocept PET/CT: A … Recruiting
  2024-514233-37-00 5 2024-07-12 Carcinoma of the parotid gland
• A study evaluating the safety and efficacy of an experimental drug for chronic lung disease against normally prescribed care in extremely pr … Recruiting
  2024-515914-41-00 4 2024-07-05 Chronic Lung Disease
• INJECTABL-II trial: Dose finding, efficacy and immunological response of a novel immuno-adjuvant (IP-001) following microwave ablation or ir … Recruiting
  2023-504572-25-00 9 2024-06-25 Colorectal liver metastases
• Drug Rediscovery for rare Immune Mediated Inflammatory Diseases (DRIMID) Recruiting
  2022-502968-20-02 4 2024-05-30 Behcet's disease

Showing 241–264 of 628 trials